US FDA – Page 51 – Express Pharma

Novartis gets US nod for long-delayed Amgen copycat

Lupin receives sANDA approval from US FDA for Levothyroxine Sodium Tablets USP

Cadila Healthcare gets EIR from US FDA for Baddi facility

FDA approves Biogen and Alkermes’ multiple sclerosis drug

Novartis’ Zolgensma study halted by FDA amid safety questions

FDA approves new breakthrough therapy for cystic fibrosis

Lupin’s Nagpur facility receives EIR from the US FDA

Indoco’s Clinical Research Organisation receives zero 483s from US FDA

US FDA red flags Glenmark over batch failure investigations at Baddi facility

Slaying GMP non-compliance woes